Exelixis, Inc.
EXEL
$38.49
$0.541.42%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
8/14/2025
-
MarketBeat
8/14/2025
-
Ticker Report
8/13/2025
-
GuruFocus
8/13/2025
-
Globe Newswire
8/13/2025
-
Zacks Investment Research
8/13/2025
-
Zacks Investment Research
8/12/2025
-
TipRanks Financial Blog
8/12/2025
-
Ticker Report
8/12/2025
-
The Fly
8/12/2025
-
Zacks Investment Research
8/11/2025
-
GuruFocus
8/11/2025
-
PR Newswire
8/10/2025
-
Simply Wall St
8/10/2025
-
Ticker Report
8/10/2025
-
MarketBeat
8/9/2025
-
Globe Newswire
8/9/2025
-
MarketBeat
8/9/2025
-
Ticker Report
8/9/2025
-
MarketBeat
8/8/2025
-
Insider Monkey
8/8/2025
-
MarketBeat
8/7/2025
-
Simply Wall St
8/7/2025
-
Ticker Report
8/7/2025
-
Ticker Report
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Monday, July 28, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Oct 27 and 31 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
650 837 7000
Address
1851 Harbor Bay Parkway
Alameda, CA 94502
Alameda, CA 94502
Country
Year Founded
Business Description
Sector
Exelixis, Inc., an oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States. The company offers...
more